Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC PHARMA   MYLAN
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-23
MYLAN
Dec-18
ALEMBIC PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs7923,975-   
Low Rs4632,188-   
Sales per share (Unadj.) Rs287.61,829.1-  
Earnings per share (Unadj.) Rs17.449.7-  
Cash flow per share (Unadj.) Rs31.4392.1-  
Dividends per share (Unadj.) Rs8.000-  
Avg Dividend yield %1.30-  
Book value per share (Unadj.) Rs222.31,978.8-  
Shares outstanding (eoy) m196.56514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.21.7 129.6%   
Avg P/E ratio x36.162.0 58.2%  
P/CF ratio (eoy) x20.07.9 254.3%  
Price / Book Value ratio x2.81.6 181.3%  
Dividend payout %46.00-   
Avg Mkt Cap Rs m123,4021,585,442 7.8%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m11,6910-   
Avg. sales/employee Rs Th026,887.8-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0730.1-  
INCOME DATA
Net Sales Rs m56,526941,074 6.0%  
Other income Rs m300-   
Total revenues Rs m56,557941,074 6.0%   
Gross profit Rs m6,772243,515 2.8%  
Depreciation Rs m2,754176,206 1.6%   
Interest Rs m50245,262 1.1%   
Profit before tax Rs m3,54622,047 16.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m126-3,507 -3.6%   
Profit after tax Rs m3,42025,554 13.4%  
Gross profit margin %12.025.9 46.3%  
Effective tax rate %3.6-15.9 -22.4%   
Net profit margin %6.12.7 222.8%  
BALANCE SHEET DATA
Current assets Rs m29,139525,495 5.5%   
Current liabilities Rs m16,408383,144 4.3%   
Net working cap to sales %22.515.1 148.9%  
Current ratio x1.81.4 129.5%  
Inventory Days Days1084 11.6%  
Debtors Days Days793 7.2%  
Net fixed assets Rs m31,498182,553 17.3%   
Share capital Rs m393501 78.5%   
"Free" reserves Rs m43,3120-   
Net worth Rs m43,7051,018,070 4.3%   
Long term debt Rs m01,098,825 0.0%   
Total assets Rs m60,6372,730,861 2.2%  
Interest coverage x8.11.5 542.5%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.90.3 270.5%   
Return on assets %6.52.6 249.4%  
Return on equity %7.82.5 311.7%  
Return on capital %9.33.2 291.3%  
Exports to sales %46.40-   
Imports to sales %12.10-   
Net fx Rs m19,3640-   
CASH FLOW
From Operations Rs m7,240195,555 3.7%  
From Investments Rs m-4,476-101,081 4.4%  
From Financial Activity Rs m-2,620-91,101 2.9%  
Net Cashflow Rs m1441,620 8.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare ALEMBIC PHARMA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ALEMBIC PHARMA With: CIPLA  AAYUSH FOOD & HERBS   SUPRIYA LIFESCIENCE   BAJAJ HEALTHCARE  FDC  



Today's Market

Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results(Closing)

It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.